XML 34 R13.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Goodwill | 12 Months Ended
--- | ---
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill | Goodwill The following table summarizes the changes in the carrying value of goodwill by operating segment for each of 2022, 2023, and 2024:
(In thousands) | North American OTC Healthcare |  | International OTC Healthcare |  |  |  | Consolidated
Balance – March 31, 2022 |  |  |  |  |  |  |
Goodwill | $ | 712,002 |  |  | $ | 32,272 |  |  |  |  | $ | 744,274 |
Accumulated impairment losses | (163,711) |  |  | (1,587) |  |  |  |  | (165,298) |
Balance - March 31, 2022 | $ | 548,291 |  |  | $ | 30,685 |  |  |  |  | $ | 578,976 |
Adjustment related to acquisition | (550) |  |  | — |  |  |  |  | (550) |
Effects of foreign currency exchange rates | — |  |  | (2,068) |  |  |  |  | (2,068) |
Impairment loss | (48,805) |  |  | — |  |  |  |  | (48,805) |
Balance – March 31, 2023 |  |  |  |  |  |  |
Goodwill | 711,452 |  |  | 30,204 |  |  |  |  | 741,656 |
Accumulated impairment losses | (212,516) |  |  | (1,587) |  |  |  |  | (214,103) |
Balance - March 31, 2023 | $ | 498,936 |  |  | $ | 28,617 |  |  |  |  | $ | 527,553 |
Additions (a) | — |  |  | 621 |  |  |  |  | 621 |
Effects of foreign currency exchange rates | — |  |  | (441) |  |  |  |  | (441) |
Balance – March 31, 2024 |  |  |  |  |  |  |
Goodwill | 711,452 |  |  | 30,384 |  |  |  |  | 741,836 |
Accumulated impairment losses | (212,516) |  |  | (1,587) |  |  |  |  | (214,103) |
Balance - March 31, 2024 | $ | 498,936 |  |  | $ | 28,797 |  |  |  |  | $ | 527,733 |
(a) On January 8, 2024, our Australian subsidiary acquired one of its suppliers. In connection with this acquisition, we preliminarily allocated $0.6 million to goodwill. At February 28, 2022, in conjunction with the annual test for goodwill impairment, which coincides with our annual strategic planning process, we recorded an impairment charge of $0.3 million to write off the remaining goodwill related to our Painstop brand in our International OTC Healthcare segment. At February 28, 2023, in conjunction with the annual test for goodwill impairment, which coincides with our annual strategic planning process, we recorded an impairment charge of $48.8 million to adjust the carrying amount of goodwill related to our North American Women's Health and North American Oral Care reporting units. The impairment charges were primarily a result of increased discount rates due to current macroeconomic conditions discussed in Note 7. At February 29, 2024, in conjunction with the annual test for goodwill impairment, which coincides with our annual strategic planning process, the estimated fair value exceeded the carrying value for all reporting units and accordingly, no impairment charge was taken. We identify our reporting units in accordance with the FASB ASC Subtopic 280. The carrying value and fair value for intangible assets and goodwill for a reporting unit are calculated based on key assumptions and valuation methodologies. The discounted cash flow methodology is a widely accepted valuation technique utilized by market participants in the transaction evaluation process and has been applied consistently. We also considered our market capitalization at February 29, 2024 and February 28, 2023, as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology. The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties related to future sales, gross margins, and advertising and marketing expenses, which can be impacted by increases in competition, changing consumer preferences, technical advances, supply chain constraints, labor shortages, and inflation. The discount rate assumption may be influenced by such factors as changes in interest rates and rates of inflation, which can have an impact on the determination of fair value. If these assumptions are adversely affected, we may be required to record additional impairment charges in the future. Our analysis at February 29, 2024 determined that all reporting units had a fair value that exceeded their carrying value by at least 10%, with the exception of the North American Women's Health reporting unit. We performed a sensitivity analysis on our weighted average cost of capital, and we determined that a 50-basis point increase in the weighted average cost of capital would have resulted in an impairment charge of $9.1 million. Additionally, a 50-basis point decrease in the terminal growth rate used for each reporting unit would not have resulted in any of our reporting units' fair value being less than their carrying value.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//350-20/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2 + Details
Name: | us-gaap_GoodwillDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration